Leveraged & Inverse Channel This Bearish Biotech ETF Is up 16% in the Past Month By Ben HernandezOctober 12, 2021
Disruptive Technology Channel Autonomous Tech ETF Could Find Support Under California Sun By Tom LydonOctober 10, 2021
ETF Building Blocks Channel Drug Price Debate May Not Hinder Biotech ETFs After All By Tom LydonSeptember 16, 2021
Disruptive Technology Channel Coinbase Slide Could Be Good for Fintech ETF By Tom LydonSeptember 15, 2021
Disruptive Technology Channel Ethereum Rebound Could Spark This Fintech ETF By Tom LydonSeptember 13, 2021
Featured Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval By Ian YoungAugust 23, 2021
Disruptive Technology Channel What Is John Deere Doing in a Disruptive Tech ETF? By Tom LydonAugust 16, 2021
Disruptive Technology Channel Corporate Moves in Crypto Could Be Fabulous for This Fintech ETF By Tom LydonJuly 19, 2021
Innovative ETFs Channel A Biotech ETF to Track Nasdaq’s Industry-Setting Benchmark By Max ChenJune 30, 2021
Leveraged & Inverse Channel 4 Tech ETFs to Play the Current Chip Shortage By Ben HernandezJune 18, 2021
Innovative ETFs Channel Will Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug? By Ian YoungJune 9, 2021
Equity ETF Channel Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
